2.94
1.38%
0.04
前日終値:
$2.90
開ける:
$2.98
24時間の取引高:
30,562
Relative Volume:
1.22
時価総額:
$196.66M
収益:
$62.37M
当期純損益:
$-78.98M
株価収益率:
-2.4098
EPS:
-1.22
ネットキャッシュフロー:
$-57.80M
1週間 パフォーマンス:
-9.82%
1か月 パフォーマンス:
-13.53%
6か月 パフォーマンス:
-35.81%
1年 パフォーマンス:
-46.55%
Sophia Genetics Sa Stock (SOPH) Company Profile
SOPH を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
3.01 | 196.66M | 62.37M | -78.98M | -57.80M | -1.22 |
VEEV
Veeva Systems Inc
|
216.69 | 35.09B | 2.66B | 665.91M | 1.08B | 4.05 |
SOLV
Solventum Corp
|
68.25 | 11.80B | 8.26B | 66.00M | 1.17B | 0.3682 |
DOCS
Doximity Inc
|
52.54 | 9.75B | 516.85M | 174.11M | 217.38M | 0.87 |
HQY
Healthequity Inc
|
100.29 | 8.68B | 1.15B | 96.70M | -161.99M | 1.09 |
WAY
Waystar Holding Corp
|
36.99 | 6.42B | 906.14M | -52.62M | 89.62M | -0.3621 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-18 | 開始されました | Craig Hallum | Buy |
2024-08-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2024-06-27 | 開始されました | Guggenheim | Buy |
2023-11-29 | 開始されました | RBC Capital Mkts | Outperform |
2023-07-05 | 再開されました | JP Morgan | Overweight |
2023-01-03 | 開始されました | BTIG Research | Buy |
2022-11-23 | 開始されました | Credit Suisse | Neutral |
2021-10-15 | 再開されました | Cowen | Outperform |
2021-08-17 | 開始されました | Cowen | Outperform |
2021-08-17 | 開始されました | Credit Suisse | Outperform |
2021-08-17 | 開始されました | JP Morgan | Overweight |
2021-08-17 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Sophia Genetics Sa (SOPH) 最新ニュース
Shareholders Should Be Pleased With SOPHiA GENETICS SA's (NASDAQ:SOPH) Price - Simply Wall St
Genomic Biomarkers Market Report: Personalized Medicine - GlobeNewswire
The Zacks Analyst Blog Highlights Tempus AI, iRhythm Technologies and SOPHiA GENETICS - Yahoo Finance
Tempus AI Stock Surges 23% In 6 Months: Should You Snap It Up Now? - Barchart
Radiomics Market Top Companies StudyRadiomics.io - openPR
Principal Financial Group Inc. Buys 86,764 Shares of SOPHiA GENETICS SA (NASDAQ:SOPH) - Defense World
JPMorgan Chase & Co. Purchases 1,399,131 Shares of iShares 5-10 Year Investment Grade Corporate Bond ETF (NASDAQ:IGIB) - Defense World
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 38.6% - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Coverage Initiated at Craig Hallum - Defense World
Guggenheim Initiates Coverage of SOPHiA GENETICS (SOPH) with Buy Recommendation - MSN
Growth Trends in Europe's Precision Medicine Software - GlobeNewswire
SOPHiA GENETICS (NASDAQ:SOPH) Now Covered by Analysts at Craig Hallum - MarketBeat
Craig-Hallum Initiates Coverage of SOPHiA GENETICS (SOPH) with Buy Recommendation - MSN
SOPHiA GENETICS's SWOT analysis: biopharma firm navigates headwinds, eyes growth - Investing.com Australia
SOPHiA GENETICS's SWOT analysis: biopharma firm navigates headwinds, eyes growth By Investing.com - Investing.com South Africa
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - MarketBeat
Precision Medicine Software Market to Witness Substantial Growth and New Opportunities from 2024 to 2031 As... - WhaTech
US Penny Stocks To Watch In December 2024 - Simply Wall St
Bioinformatics Market to Grow by USD 13.2 Billion (2024-2028), Lower Genetic Sequencing Costs Drive Revenue, Report Highlights AI's Role in TransformationTechnavio - The Malaysian Reserve
SOPHiA GENETICS Reports Third Quarter 2024 Results - GuruFocus.com
Principal Financial Group Inc. Acquires 86,764 Shares of SOPHiA GENETICS SA (NASDAQ:SOPH) - Defense World
SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024 – Company Announcement - Financial Times
SOPHiA GENETICS Launches Advanced Cancer Profiling Platform with 99.3% Accuracy - StockTitan
SOPHiA GENETICS's SWOT analysis: data-driven medicine stock faces headwinds - Investing.com India
SOPHiA GENETICS (NASDAQ:SOPH) vs. SpringWorks Therapeutics (NASDAQ:SWTX) Financial Review - Defense World
Earnings Release: Here's Why Analysts Cut Their SOPHiA GENETICS SA (NASDAQ:SOPH) Price Target To US$6.00 - Yahoo Finance
SOPHiA GENETICS SA (NASDAQ:SOPH) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: SOPHiA GENETICS reported a16% year-over-year increase in analysis volume - Investing.com
SOPHiA GENETICS Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
SOPHiA GENETICS Faces Financial Challenges Amid Losses - Yahoo Finance
Sophia Genetics SA (SOPH) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
SOPHiA GENETICS Q3 2024 Financial Highlights - TipRanks
SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer - Marketscreener.com
3 Reasons Not to Give Up on Roku Stock - MSN
Vanguard Dethrones BlackRock As Second Largest ETF Manager: Here's How Their Funds With Exposure To S&P 500 Fared This Year - MSN
SOPHiA GENETICS Strengthens Leadership: Names New President, Appoints Industry Veteran CFO - StockTitan
Cofle S.p.A. Enhances Share Buyback Strategy - MSN
Adma Biologics (ADMA) Soars 18.8%: Is Further Upside Left in the Stock? - MSN
Palantir, Trump Media Buzz Amid Investors Ahead Of Election Day - MSN
SOS Limited announces ADS ratio change - MSN
Exploring Sophia Genetics's Earnings Expectations - Benzinga
Denmark stocks lower at close of trade; OMX Copenhagen 20 down 1.16% - MSN
IPO Roundup: Heritage Distilling, Transten Global and more - MSN
SOPHiA GENETICS SA (SOPH): A Bull Case Theory - Insider Monkey
Sophia Genetics SA (SOPH) Q3 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Estimating at-risk couple rates across 1000 exome sequencing data cohort for 176 genes and its importance relevance for health policies - Nature.com
Fulgent Genetics (FLGT) Surges 5.8%: Is This an Indication of Further Gains? - Yahoo Finance
Morgan Stanley Downgrades Biogen (BIIB) - MSN
The biggest U.S. homebuilder misses on earnings as it says buyers are staying on the sidelines - MSN
Clime Capital Announces Quotation of New Shares - MSN
SOPHiA GENETICS (SOPH) to Release Quarterly Earnings on Tuesday - MarketBeat
Sophia Genetics Sa (SOPH) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):